These results indicated that the methylation status of BAIAP2L2 might be positively correlated with immunosuppression status, and thus the methylation level of BAIAP2L2 could serve as a potential prognostic biomarker and might play a critical role in the progression of HCC. This evidence concerns the gene BAIAP2L2 and hepatocellular carcinoma.